Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

Concurrent H1 antihistamines associated with better survival in BCG-treated bladder cancer
21 Dec 2025
bởiNatalia Reoutova
Use of H1 antihistamines (H1-AH) during intravesical bacillus Calmette-Guérin (BCG) immunotherapy is associated with better overall survival (OS), cancer-specific survival (CSS), recurrence-free survival (RFS), and progression-free survival (PFS) in patients with non–muscle-invasive bladder cancer (NMIBC), according to a territory-wide retrospective observational study by researchers from the Chinese University of Hong Kong.
21 Dec 2025







